UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Patient-Derived Organoids Can Guide Personalized-Therapies for Patients with Advanced Breast Cancer Journal article
Ping Chen, Xu Zhang, Renbo Ding, Linglin Yang, Xueying Lyu, Jianming Zeng, Josh Haipeng Lei, Lijian Wang, Jiong Bi, Nan Shao, Ditian Shu, Bin Wu, Jingbo Wu, Zhihui Yang, Haiyan Wang, Biqiong Wang, Kang Xiong, Yun Lu, Shaozhi Fu, Tak Kan Choi, Ng Wai Lon, Aiping Zhang, Dongyang Tang, Yingyao Quan, Ya Meng, Kai Miao, Heng Sun, Ming Zhao, Jiaolin Bao, Lei Zhang, Xiaoling Xu, Yanxia Shi, Ying Lin, Chuxia Deng. Patient-Derived Organoids Can Guide Personalized-Therapies for Patients with Advanced Breast Cancer[J]. Advanced Science, 2021, 8(22), 2101176.
Authors:  Ping Chen;  Xu Zhang;  Renbo Ding;  Linglin Yang;  Xueying Lyu; et al.
Favorite | TC[WOS]:75 TC[Scopus]:75  IF:14.3/16.3 | Submit date:2021/11/30
Advanced Breast Cancer  Drug Screening  Patient-derived Organoids  Personalized Therapy  
Enhanced Protein Damage Clearance Induces Broad Drug Resistance in Multitype of Cancers Revealed by an Evolution Drug-Resistant Model and Genome-Wide siRNA Screening Journal article
Shao,Fangyuan, Lyu,Xueying, Miao,Kai, Xie,Lisi, Wang,Haitao, Xiao,Hao, Li,Jie, Chen,Qiang, Ding,Renbo, Chen,Ping, Xing,Fuqiang, Zhang,Xu, Luo,Guang Hui, Zhu,Wenli, Cheng,Gregory, Lon,Ng Wai, Martin,Scott E., Wang,Guanyu, Chen,Guokai, Dai,Yunlu, Deng,Chu Xia. Enhanced Protein Damage Clearance Induces Broad Drug Resistance in Multitype of Cancers Revealed by an Evolution Drug-Resistant Model and Genome-Wide siRNA Screening[J]. Advanced Science, 2020, 7(23), 2001914.
Authors:  Shao,Fangyuan;  Lyu,Xueying;  Miao,Kai;  Xie,Lisi;  Wang,Haitao; et al.
Favorite | TC[WOS]:11 TC[Scopus]:12  IF:14.3/16.3 | Submit date:2021/03/02